Novavax | 4: Statement of changes in beneficial ownership of securities-Director Alton Gregg H
Novavax | 4: Statement of changes in beneficial ownership of securities-Director MCGLYNN MARGARET G
Novavax | SCHEDULE 13G/A: Others
Novavax | 4: Statement of changes in beneficial ownership of securities-Officer Jacobs John C
Novavax | 8-K: Investor Presentation
Novavax | 4: Statement of changes in beneficial ownership of securities-Officer Kelly James Patrick
Novavax | 4: Statement of changes in beneficial ownership of securities-Director Rodgers Richard J
Novavax | 4: Statement of changes in beneficial ownership of securities-Director King Rachel K.
Novavax | 4: Statement of changes in beneficial ownership of securities-Director YOUNG JAMES F
Novavax | 144/A: Others
Novavax | 8-K: Asset Purchase Agreement
Novavax | 144: Notice of proposed sale of securities pursuant to Rule 144
Novavax | 8-K: Amendment No. 5 to the Advance Purchase Agreement
Novavax | 4: Statement of changes in beneficial ownership of securities-Officer Casey Mark J
Novavax | 144: Notice of proposed sale of securities pursuant to Rule 144
Novavax | 8-K: Asset Purchase Agreement
Novavax | 8-K: Investor Presentation
Novavax | 3: Initial statement of beneficial ownership of securities-Officer Draghia-Akli Ruxandra
Novavax | 4: Statement of changes in beneficial ownership of securities-Officer Draghia-Akli Ruxandra
Novavax | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(9.63%)